Friday, November 28, 2014

Top Financial Stocks For 2014

Morgan Stanley (MS) is in the market today with a new preferred stock issue.

Morgan Stanley, a bank holding company, provides diversified financial services on a worldwide basis. The Company operates a global securities business which serves individual and institutional investors and investment banking clients. Morgan Stanley also operates a global asset management business.

The details are (from the prospectus):

IssuerMorgan Stanley Size$250,000,000 Series/TickerSeries E - MSPrE (expected) RatingBa3/BB+/BB/BBB (Moody's/S&P/Fitch/DBRS)- expected Rate TypeFixed to float Rate7% plus (closer to 7.25%). Floats after 10/15/2023 at 3mo LIBOR + MaturityPerpetual Optional Redemption10/15/2023 CumulativeNO Tax TreatmentDRD/QDI

In order to discern if there is value (and pricing) a look at their existing preferreds is in order:

Best Tech Companies To Own For 2015: Alliance Capital Management Holding L.P. (AB)

AllianceBernstein Holding L.P. provides investment management and related services in the United States and internationally. It offers institutional services, including separately-managed accounts, sub-advisory relationships, structured products, collective investment trusts, mutual funds, hedge funds, and other investment vehicles to unaffiliated corporate and public employee pension funds, endowment funds, domestic and foreign institutions, and governments. The company also provides retail services comprising retail mutual funds, sub-advisory relationships with mutual funds sponsored by third parties, and separately managed account programs sponsored by various financial intermediaries and other investment vehicles. In addition, it provides separately managed accounts, hedge funds, mutual funds, and other investment vehicles for private clients, including high-net-worth individuals, trusts and estates, charitable foundations, partnerships, and private and family corporat ions. Further, AllianceBernstein Holding L.P. offers research services to institutional investors through research, portfolio analysis, and brokerage-related services; and equity capital markets services to issuers of publicly-traded securities. Additionally, it provides distribution, shareholder servicing, and administrative services to its sponsored mutual funds. AllianceBernstein Corporation serves as the general partner of the company. AllianceBernstein Holding L.P. was founded in 1987 and is based in New York, New York. AllianceBernstein Holding L.P. operates as a subsidiary of AXA.

Advisors' Opinion:
  • [By J. Royden Ward]

    AllianceBernstein LP (AB), a master limited partnership, is one of the largest US investment advisors. It actively manages stock and bond accounts for institutions, mutual funds, and well-heeled clients.

  • [By J. Royden Ward]

    AllianceBernstein Holding LP (AB) offers high quality research and diversified investment services to institutional investors and private clients in major global markets. The company is one of the largest US investment advisors, with assets under management totaling $445 billion, as of January 31.

  • [By Dan Caplinger]

    In the following video, Dan Caplinger, The Motley Fool's director of investment planning, goes through a few situations where an IRA rollover might not be ideal. Dan notes that Franklin Templeton (NYSE: BEN  ) , AllianceBernstein (NYSE: AB  ) , Goldman Sachs (NYSE: GS  ) , and other companies often offer cheaper class of mutual funds that would otherwise carry sales loads or higher fees outside a 401(k). Dan also talks about company stock and the special rules for 401(k)s that own it, as well as the importance of looking at overall fees to decide if your 401(k) is the best place to invest or whether an IRA rollover will help you more.

Top Financial Stocks For 2014: Agree Realty Corp (ADC)

Agree Realty Corporation, incorporated in December 1993, is a self-administered and self-managed real estate investment trust (REIT). The Company�� operations are conducted through, directly or indirectly, Agree Limited Partnership (Operating Partnership), of which the Company is the sole general partner, and in which it 96.59% interest as of December 31, 2011. The Company is focused primarily on the ownership, development, acquisition and management of retail properties net leased to national tenants. It specializes in acquiring and developing single tenant net leased retail properties for industry retail tenants. As of December 31, 2011, approximately 96% of its annualized base rent was derived from national tenants and regional tenants. At December 31, 2011, its portfolio consisted of 87 properties, located in 21 states containing an aggregate of approximately 3.6 million square feet of gross leasable area (GLA). At December 31, 2011, its portfolio included 75 freestanding single tenant net leased properties and 12 community shopping centers that were 92.7% leased. All of its freestanding property tenants and the majority of its community shopping center tenants have triple-net leases, which require the tenant to be responsible for property operating expenses, including property taxes, insurance and maintenance. In December 2012, the Company acquired LA Fitness and an AutoZone. In January 2013, the Company acquired 317 South State Street for redevelopment. In December 2012, the Company acquired a portfolio of four Applebee's restaurants, as well as an Advance Auto Parts. In Jnauary 2013, the Company sold Walgreens on Michigan Avenue in Ypsilanti , Michigan. In January 2013, it acquired Dick's Sporting Goods and Petsmart in St. Joseph, Missouri. In March 2013, it acquired three single tenant assets leased to retailers. In May 2013, the Company acquired two single tenant assets leased to Petsmart and Starbucks. In June 2013, Agree Realty Corp announced that it has acquired two single tenant assets ! leased to Wal-Mart Stores and AutoZone. In August 2013, Agree Realty Corporation acquired four single tenant assets leased to industry retailers. In September 2013, Agree Realty Corporation acquired an 112,230 square foot BJ's Wholesale Club located on Airport Road South in Allentown, Pennsylvania. In November 2013, Agree Realty Corp acquired two assets net leased to The Goodyear Tire & Rubber Company and Mattress Firm, Inc. In January 2014, the Company acquired Cannon Station in Fort Oglethorpe, Georgia. In February 2014, the Company announced the acquisition of two net lease properties and sale of Ironwood Commons shopping center.

In January 2011, the Company acquired a retail property net leased to AT&T located at the northwest corner of New Centre Drive and South College Road in Wilmington, North Carolina. In October 2011, it acquired a retail property leased on a long-term basis to Kohl's Department Stores, Inc. in Salt Lake City, Utah. In December 2011, the Company acquired Wawa convenience store and fuel station in Baltimore, Maryland, as well as a Walgreens pharmacy in Fort Walton Beach, Florida, and a CVS pharmacy in Leawood, Kansas. In May 2012, the Company acquired a 133,000 square foot retail property ground leased to Lowe's Home Improvement in Portland, Oregon. In June 2012, the Company sold the Charlevoix Commons shopping center in Charlevoix. In June 2012, the Company acquired a store leased to Dollar General Market in Cochran, Georgia, as well as the fee interest in the land underlying its Walgreens store in Ann Arbor, Michigan. In July 2012, the Company acquired a portfolio of three Wawa convenience and fuel stores. The stores are located in Clifton Heights, Pennsylvania, Newark, Delaware and Vineland, New Jersey and are master leased by Wawa. In July 2012, it acquired auto service store in Fort Mill, South Carolina leased to Goodyear Tire & Rubber Company. In August 2012, the Company closed on the acquisition of a parcel of land in Pinellas County, Florida. In August 2012,! the Comp! any sold Plymouth Commons shopping center and the Shawano Plaza shopping center. In September 2012, it acquired a Family Dollar store in Spartanburg, South Carolina, a USAA Financial Services Center in Jacksonville, North Carolina and an AutoZone store in Springfield, Illinois. In September 2012, it disposed its remaining assets that were formerly leased to Borders. In September 2012, the Company acquired a a parcel of land in Casselberry, Florida for the development of gas and convenience retailing. In November 2012, the Company acquired a Harris Teeter supermarket in Charlotte, North Carolina. In November 2012, the Company acquired a Big Lots store and a Dollar General Market.

Freestanding Properties

At December 31, 2011, the Company's 75 operating freestanding properties were leased to Walgreens (30), Rite Aid (7), CVS (6), Kmart (2), JP Morgan Chase (3), Los Tres Amigos (1), Dick�� Sporting Goods (1), Lake Lansing RA Associates, LLC (1), Meijer (1), Wal-Mart (Sam�� Club) (1), Kohl�� (2), PNC Bank (1), Lowe�� (1), Off Broadway Shoes (1), Wawa (1), Simply Amish (1), Advance Auto (1), Aldi (1), Natural Grocers (1), AT&T (1), TBC Tire stores (2), Books-A-Million (1), and vacant (8). Its freestanding properties provided $23,953,036, or approximately 70.4%, of its annualized base rent as of December 31, 2011, at an average base rent per square foot of $14.10. These properties contain, in the aggregate, 1,697,953 square feet of GLA or approximately 48% of its total GLA as of December 31, 2011. Of its 75 operating freestanding properties, 47 were developed by the Company. Its freestanding properties had a weighted average remaining lease term of 14.8 years as of December 31, 2011. The Company�� freestanding properties range in size from range in size from 3,215 to 170,393 square feet of GLA and are located in Arizona (one), California (one), Connecticut (one), Florida (one), Georgia (two), Illinois (four), Indiana (two), Kansas (four), Maryland (three), Michigan (36), Neb! raska (tw! o), New Jersey (one), New York (two), North Carolina (two), Ohio (two), Oklahoma (one), Pennsylvania (one), Texas (one), and Utah (one).

Community Shopping Centers

The Company�� 12 community shopping centers range in size from 20,000 to 241,458 square feet of GLA. The community shopping centers are located in five states: Florida (one), Illinois (one), Kentucky (one), Michigan (six) and Wisconsin (three). The Company�� community shopping centers are located in high traffic centers, in which customers of its tenants purchase day-to-day necessities. The Company�� community shopping centers are anchored by national tenants.

Advisors' Opinion:
  • [By Eric Volkman]

    The position vacated by Salix in the S&P SmallCap 600 will be filled by Agree Realty (NYSE: ADC  ) . Elsewhere on that index, DXP Enterprises (NASDAQ: DXPE  ) �will replace True Religion Apparel (NASDAQ: TRLG  ) . As with Gardner Denver in the S&P MidCap 400, True Religion Apparel is being acquired, in this case by private equity firm TowerBrook Capital Partners.

  • [By Eric Volkman]

    Agree Realty (NYSE: ADC  ) this week declared a second-quarter distribution of $0.41 per share to be paid on July 9 to shareholders of record as of June 28.

Top Financial Stocks For 2014: The NASDAQ OMX Group Inc.(NDAQ)

The NASDAQ OMX Group, Inc. provides trading, clearing, exchange technology, securities listing, and public company services worldwide. It offers trading across various asset classes, including cash equities, derivatives, debt, commodities, structured products, and exchange traded funds; capital formation solutions; financial services and exchanges technology; market data products; and financial indexes, as well as clearing, settlement, and depository services. The company also provides broker services comprising technology and customized securities administration solutions, such as back-office systems to financial participants. In addition, it offers global listing services; technology solutions for trading, clearing, settlement, and information dissemination; and facility management integration, surveillance solutions, and advisory services, as well as develops and licenses NASDAQ OMX branded indexes, associated derivatives, and financial products. As of December 31, 2010 , a total of 2,778 companies listed securities on The NASDAQ Stock Market. The NASDAQ OMX Group supports the operations of approximately 70 exchanges, clearing organizations, and central securities depositories. The company was formerly known as The Nasdaq Stock Market, Inc. and changed its name to The NASDAQ OMX Group, Inc. in February 2008. The NASDAQ OMX Group, Inc. was founded in 1971 and is based in New York, New York.

Advisors' Opinion:
  • [By Matt Egan]

    IntercontinentalExchange (ICE), which owns NYSE, didn't get much of a bump from the news. Its shares were slightly higher. Nasdaq OMX Group (NDAQ)actually rose more than 1% despite losing out on Alibaba.

Top Financial Stocks For 2014: Fifth Third Bancorp (FFH)

Fifth Third Bancorp (the Bancorp), incorporated on October 7, 1974, is a diversified financial services company. As of December 31, 2011, the Bancorp had $117 billion in assets, operated 15 affiliates with 1,316 full-service Banking Centers, including 104 Bank Mart locations open seven days a week inside select grocery stores, and 2,425 automated teller machines (ATMs) in 12 states throughout the Midwestern and Southeastern regions of the United States. The Bancorp operates in four business segments: Commercial Banking, Branch Banking, Consumer Lending and Investment Advisors. The Bancorp also has a 49% interest in Vantiv Holding, LLC.

Commercial Banking

Commercial Banking offers credit intermediation, cash management and financial services to large and middle-market businesses and government and professional customers. In addition to the traditional lending and depository offerings, Commercial Banking products and services include global cash management, foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing and syndicated finance.

Branch Banking

Branch Banking provides a range of deposit and loan and lease products to individuals and small businesses through 1,316 full-service Banking Centers. Branch Banking offers depository and loan products, such as checking and savings accounts, home equity loans and lines of credit, credit cards and loans for automobiles and other personal financing needs, as well as products designed to meet the specific needs of small businesses, including cash management services.

Consumer Lending

Consumer Lending includes the Bancorp�� mortgage, home equity, automobile and other indirect lending activities. Mortgage and home equity lending activities include the origination, retention and servicing of mortgage and home equity loans or lines of credit, sales and securitizations of t! hose loans, pools of loans or lines of credit, and all associated hedging activities. Indirect lending activities include loans to consumers through mortgage brokers and automobile dealers.

Investment Advisors

Investment Advisors provides a range of investment alternatives for individuals, companies and not-for-profit organizations. Investment Advisors is made up of four main businesses: Fifth Third Securities (FTS), an indirect wholly owned subsidiary of the Bancorp; Fifth Third Asset Management, Inc. (FTAM), an indirect wholly owned subsidiary of the Bancorp; Fifth Third Private Bank; and Fifth Third Institutional Services. FTS offers full service retail brokerage services to individual clients and broker dealer services to the institutional marketplace. FTAM provides asset management services and also advises the Bancorp�� family of mutual funds. Fifth Third Private Bank offers holistic strategies to affluent clients in wealth planning, investing, insurance and wealth protection. Fifth Third Institutional Services provide advisory services for institutional clients including states and municipalities.

Advisors' Opinion:
  • [By gurufocus]

    Prem Watsa, highly regarded CEO of Fairfax Financial Holdings Ltd. (FFH), wrote in March that ��e continue to fully hedge our common stock portfolios as our concerns about the United States��� You would think he has been wrong with the hedging as he is losing money with them. But the last time he was losing with hedging was during the last bull market from 2004 to 2006. He then made a killing with the hedges in 2007 and 2008.

Top Financial Stocks For 2014: Astoria Financial Corp (AF)

Astoria Financial Corporation, incorporated on June, 14, 1993, is the unitary savings and loan association holding company of Astoria Federal Savings and Loan Association (Astoria Federal). The Company�� principal business is the operation of its wholly owned subsidiary, Astoria Federal. Astoria Federal�� primary business is attracting retail deposits from the general public and investing those deposits, together with funds generated from operations, principal repayments on loans and securities and borrowings, primarily in one- to four-family mortgage loans, multi-family mortgage loans, commercial real estate loans and mortgage-backed securities. Astoria Federal also invests in consumer and other loans, the United States Government, government agency and government-sponsored enterprise (GSE), securities and other investments.

Lending Activities

The Company�� loan portfolio consists primarily of mortgage loans. As of December 31, 2012, 74% of its total loan portfolio was secured by residential properties and 24% was secured by multi-family properties and commercial real estate. The remainder of the loan portfolio consists of a variety of consumer and other loans, including commercial and industrial loans originated in 2012 through its business banking initiatives. As of December 31, 2012, its net loan portfolio totaled $13.08 billion, or 79% of total assets. The Company originates mortgage loans either directly through its banking and loan production offices in New York or indirectly through brokers and its third party loan origination program. It also originates mortgage loans for sale. The Company�� primary lending focus is on the origination and purchase of first mortgage loans secured by one- to four-family properties that serve as the primary residence of the owner.

The Company also originates multi-family and commercial real estate loans. As of December 31, 2012, multi-family mortgage loans totaled $2.41 billion, or 18% of its total loan portfolio,! and commercial real estate loans totaled $773.9 million, or 6% of its total loan portfolio. At December 31, 2012, $264.1 million, or 2%, of the Company�� total loan portfolio consisted of consumer and other loans which were primarily home equity lines of credit. The Company also offers overdraft protection, lines of credit, commercial loans and passbook loans. Consumer and other loans, with the exception of home equity and commercial lines of credit, are offered primarily on a fixed rate, short-term basis.

Investment Activities

At December 31, 2012, the Company�� securities portfolio totaled $2.04 billion, or 12%, of total assets. The Company does not use derivatives for trading purposes. Its securities portfolio consists primarily of mortgage-backed securities. At December 31, 2012, its mortgage-backed securities totaled $1.94 billion, or 95%, of total securities, of which $1.92 billion, or 94%, of total securities, were real estate mortgage investment conduits (REMIC) and collateralized mortgage obligation (CMO) securities, substantially all of which had fixed rates. Of the REMIC and CMO securities portfolio, $2.35 billion, or 98.7%, are guaranteed by Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac) or Government National Mortgage Association (Ginnie Mae) as issuer. At December 31, 2012, its securities available-for-sale totaled $336.3 million and its securities held-to-maturity totaled $1.7 billion. At December 31, 2012, it had no investments in repurchase agreements and federal funds sold.

Sources of Funds

The Company�� primary source of funds is the cash flow provided by its investing activities, including principal and interest payments on loans and securities. Its other sources of funds are provided by operating activities and financing activities, including deposits and borrowings. The Company offers a variety of deposit accounts with a range of interest rates and terms. It offers ! passbook ! and statement savings accounts, money market accounts, negotiable order of withdrawal (NOW) and demand deposit accounts, liquid certificates of deposit (Liquid CDs), and certificates of deposit, which include all time deposits other than Liquid CDs. Liquid CDs have maturities of three months, require the maintenance of a minimum balance and allow depositors the ability to make periodic deposits to and withdrawals from their account. At December 31, 2012, its deposits totaled $10.44 billion. Of the total deposit balance, $1.28 billion, or 12%, represented individual retirement accounts during the year ended December 31, 2012. It held no brokered deposits at December 31, 2012. Core deposits represented 53.3% of total deposits at December 31, 2011. Reverse repurchase agreements are accounted for as borrowings and are secured by the securities sold under the agreements. At December 31, 2012, borrowings totaled $4.37 billion. It also obtains advances from the Federal Home Loan Bank of New York (FHLB-NY).

Subsidiary Activities

In addition to Astoria Federal, the Company has two other subsidiaries, AF Insurance Agency, Inc. and Astoria Capital Trust I. AF Insurance Agency, Inc. is a life insurance agency. Through contractual agreements with various third parties, AF Insurance Agency, Inc. makes insurance products available primarily to the customers of Astoria Federal. Astoria Federal�� wholly owned subsidiaries include AF Agency, Inc., Astoria Federal Savings and Loan Association Revocable Grantor Trust, Astoria Federal Mortgage Corp. (AF Mortgage), Fidata Service Corp. (Fidata), Marcus I Inc. and Suffco Service Corporation (Suffco). AF Agency, Inc. makes various annuity products available to the customers of Astoria Federal through an unaffiliated third party vendor. AF Mortgage is an operating subsidiary through which Astoria Federal engages in lending activities outside the State of New York through its third party loan origination program. Fidata mortgage loans totaled $5.09 bi! llion at ! December 31, 2012. Suffco serves as document custodian for the loans of Astoria Federal and Fidata and certain loans being serviced for Fannie Mae and other investors.

Advisors' Opinion:
  • [By Jonathan Morgan]

    Air France-KLM Group (AF), Europe�� second-biggest airline by sales, retreated 2.8 percent. Mediaset SpA climbed 2.8 percent after Credit Suisse Group AG raised its price target on the Italian broadcaster. Serco Group Plc added 2.7 percent after predicting that its revenue growth in the first half will exceed its previous estimates.

  • [By Namitha Jagadeesh]

    International Consolidated Airlines Group SA (IAG) and Air France-KLM (AF) Group rose with as a gauge of travel stocks as oil prices fell after Iran�� accord. PSA Peugeot Citroen gained 3.7 percent after people familiar with the matter said its chief executive officer plans to step down next year. Fresenius Medical Care AG surged the most in five years after U.S. regulators scrapped a plan to cut Medicare payments next year.

Top Financial Stocks For 2014: MarketAxess Holdings Inc (MKTX)

MarketAxess Holdings Inc. (MarketAxess), incorporated on April 11, 2000, operates an electronic trading platform that allows investment industry professionals to trade corporate bonds and other types of fixed-income instruments. The Company�� over 1000 active institutional investor clients (firms that executed at least one trade in the United States or European fixed-income securities through its electronic trading platform, during the year ended December 31, 2012) include investment advisers, mutual funds, insurance companies, public and private pension funds, bank portfolios, broker-dealers and hedge funds. The Company�� 87 broker-dealer, market-maker clients provide liquidity on the platform and include most of the broker-dealers in global fixed-income trading. Through its Corporate BondTicker service, MarketAxess provides fixed-income market data, analytics and compliance tools that help its clients make trading decisions. In addition, it provides Financial Information eXchange (FIX) message management tools, connectivity solutions and ancillary technology services that facilitate the electronic communication of order information between trading counterparties. The Company�� revenues are primarily generated from the trading of the United States high-grade corporate bonds. In March 2013, it announced acquisition of Xtrakter Limited.

The majority of the Company's revenues are derived from monthly distribution fees and commissions for trades executed on its platform that are billed to its broker-dealer clients on a monthly basis. The Company also derives revenues from technology products and services, information and user access fees, investment income and other income. During 2012, the Company�� broker-dealer clients accounted for approximately 95% of the underwriting of newly-issued United States corporate bonds and approximately 72% of the underwriting of newly issued European corporate bonds. MarketAxess�� electronic trading platform provides access to the liquidity provide! d through the participation on its platform of 87 broker-dealer market making clients, including all of the broker-dealers in global fixed-income trading, and over 1000 active institutional investor firms. In addition to services directly related to the execution of trades, the Company offers its clients several other services, including information services, straight-through processing, and technology products and services. MarketAxess offers Application Programming Interface (API) services to its broker-dealer clients for pre-trade, trade negotiation and post-trade services.

The United States High-Grade Corporate Bonds

The United States corporate bond market consists of three categories of securities: investment-grade debt (so-called high-grade); debt rated below investment-grade (so-called high-yield), and debt convertible into equity (so-called convertible debt). The Company�� United States high-grade corporate bond business consists of the United States dollar-denominated, investment-grade debt issued by corporations for distribution in the United States. Both domestic and foreign institutional investors have access to the United States high-grade corporate bond trading on its electronic trading platform. During 2012, its broker-dealer clients accounted for approximately 95% of the underwriting of newly-issued the United States corporate bonds. The Company offers its institutional investor clients access to a range of inventory of the United States high-grade corporate bonds, which is provided and updated daily by its broker-dealer clients.

Eurobonds

The European high-grade corporate bond market consists of a range of products, issuers and currencies. MarketAxess Europe Limited, its wholly owned subsidiary, offers European secondary trading functionality in the United States dollar- and Euro-denominated European corporate bonds to its broker-dealer and institutional investor clients. The Company also offers its clients to trade in other European! high-gra! de corporate bonds, including bonds issued in Pounds Sterling, floating rate notes, European government bonds and bonds denominated in non-core currencies. In the Eurobond credit market, defined as including European high-grade, high yield and government bonds, 23 broker-dealers utilize the Company�� platform.

Emerging Markets Bonds

Emerging markets bond market includes the United States dollar, Euro or local currency denominated bonds issued by sovereign entities or corporations domiciled in a developing country. These issuers are located in Latin America, Asia, or Central and Eastern Europe. The agency bond market includes debt issued by a United States government-sponsored enterprise. 59 of the Company�� United States broker-dealer clients use its platform to trade emerging markets bonds. During 2011, 414 institutional investor clients utilized its electronic trading platform to trade emerging markets bonds. These institutional investor clients are located in the United States and Europe. MarketAxess also allows its institutional investor clients to transact Euroclear-eligible local currency denominated bonds issued by sovereign entities or corporations in countries that include Argentina, Brazil and Mexico.

Crossover and High-Yield Bonds

59 of the Company�� United States broker-dealer clients use its platform to trade crossover and high-yield bonds. Trading in crossover and high-yield bonds uses many of the same features available in its United States high-grade corporate bond offering.

Agency Bonds

41 of the Company�� United States broker-dealer clients use its platform to trade agency bonds. Trading in agency bonds uses many of the same features available in the Company�� United States high-grade corporate bond offering.

Credit Default Swaps

MarketAxess offers trading on its platform for CDS indices and single-names in both the United States and Europe through its traditional RFQ proto! col. Nine! of the Company�� broker-dealer clients are providing streaming, executable CDS index prices. In addition, it incorporated the request-for-market protocol and the streaming markets/click-to-trade protocol into an updated single-screen user interface, giving clients their means of execution.

Asset-Backed Securities

12 of its United States broker-dealer clients use its platform to trade asset-backed securities. Trading in asset-backed securities uses many of the same features available in the Company�� United States high-grade corporate bond offering.

Preferred Securities

17 of the Company�� United States broker-dealer clients use its platform to trade preferred securities. Trading in preferred securities uses many of the same features available in its United States high-grade corporate bond offering.

Corporate BondTicker

Corporate BondTicker provides TRACE data and enhances it with MarketAxess trade data and analytical tools to provide professional market participants with a set of corporate bond price information. The data include trade time and sales information, including execution prices, as well as MarketAxess-estimated, spread-to-Treasuries, for trades disseminated by the TRACE system. The data also include actual execution prices and spread-to-Treasury levels for United States high-grade corporate bond trades executed on the MarketAxess platform. Corporate BondTicker is integrated directly into the MarketAxess electronic trading platform and can be accessed, either when viewing securities inventory or when launching an inquiry. Corporate BondTicker is also available through the Internet for non-trading professional market participants, including, among others, research analysts and rating agencies, who can log in and access the information via an easy-to-use browser-based interface.

The Company provides Corporate BondTicker as an ancillary service to its trading clients and also to other industry parti! cipants. ! It derives revenues from its Corporate BondTicker service by charging for seat licenses per user at its broker-dealer and institutional investor clients, through distribution agreements with other information service providers and through bulk data sales to third parties. The Company also offers a set of reports designed to review and monitor credit trading activity for institutional investor clients. Its compliance product provides a printed history of each inquiry submitted through the MarketAxess trading platform.

Technology Services

Through MarketAxess�� Greenline Financial Technologies, Inc. (Greenline) subsidiary, it provides integration, testing and management solutions for FIX-related products and services. The FIX protocol is a messaging standard developed for the electronic exchange of securities transaction information. It also provides technology consulting and customized development services to its clients. In addition, the Company provides gateway adapters to connect order management and trading systems to fixed-income trading venues.

The Company competes with Thomson TradeWeb, Bloomberg and The New York Stock Exchange

Advisors' Opinion:
  • [By Alex Dumortier, CFA]

    MarketAxess (NASDAQ: MKTX  ) published its third-quarter results�(link opens a PDF) this morning, and as the following table shows, the numbers were disappointing -- by Wall Street's standards. The fixed-income trading platform missed on both revenues and earnings per share. Those misses have short-term investors spooked today, and shares are down around 5.5%. Long-term investors, on the other hand, ought to be a little more sanguine. I don't see any signs that the business franchise is impaired, and, although investors will need to continue monitoring potential competitors and, particularly, structural developments in the bond markets, the latest set of results are well within the bounds of normal business fluctuations.

Top Financial Stocks For 2014: National Health Partners Inc (NHPR)

National Health Partners, Inc., incorporated on March 10, 1989, is a national healthcare membership organization that was formed to address the need for affordable healthcare nationwide. The Company creates, markets and sells membership programs targeted toward underserved markets in the healthcare industry through a national healthcare savings network called CARExpress. CARExpress is a network of over 1,000,000 participating hospitals, doctors, dentists, pharmacists and other healthcare providers that have agreed to render their services and products to the Company's members at discounted prices. CARExpress enables the Company's members to engage in point-of-service transactions directly with participating healthcare providers and pay discounted prices.

The Company has designed membership programs that range from its traditional health discount programs that provide access to networks of providers that have agreed to provide its members with a reduced rate for services, to membership programs that include limited liability insurance benefits. The Company offers two families of CARExpress membership programs to its members, its CARExpress health discount programs, and its CARExpress Plus membership programs.

The Company's CARExpress health discount programs consists of healthcare, including physicians, hospitals, ancillary services, dentists, prescription drugs, vision care, hearing aids, chiropractic services, alternative care, 24-hour nurseline, medical supplies and equipment, and long-term care facilities, which include skilled nursing facilities, assisted living facilities, respite care and home health care. The Company provides its members with access to over 1,000,000 healthcare providers through its agreements with CareMark, Aetna, Optum, Outlook Vision, Integrated Health, Three Rivers, International Med-Care and HealthFi International.

The Company's CARExpress Plus programs are membership programs consists of the Company's CARExpress health discount progr! ams and limited liability insurance benefits underwritten by United States.The limited liability insurance benefits included in these programs are accidental death and dismemberment coverage (AD&D), accident medical expense coverage (AME), accident disability coverage, a daily hospital and intensive care unit (ICU) benefit, doctor visit benefits, inpatient/outpatient surgical visit benefits, as well as emergency room and ambulance benefits. With CARExpress Plus, the Company's health discount programs provide its members with a point of service discount on their healthcare expenses at the time of service. The Company offers three standard CARExpress Plus programs, which include CARExpress Plus Platinum Program, CARExpress Plus Gold Program and CARExpress Plus Silver Program.

The Company competes with Alliance HealthCard, Inc., AmeriPlan, Best Benefits, Careington International, Family Care, Full Access Medical, International Association of Businesses, New Benefits, Inc. and People's Benefit Services.

Advisors' Opinion:
  • [By Peter Graham]

    Last Friday, small cap stocks National Health Partners, Inc (OTCMKTS: NHPR) surged 816.7% while Timios National Corp (OTCMKTS: HOMS) and Medical Care Technologies Inc (OTCMKTS: MDCE) sank 32.28% and 25%, respectively. So what will these three small caps do for investors and traders this week? Here is a closer look to help you decide on a trading strategy:

    National Health Partners, Inc (OTCMKTS: NHPR) Surged 816.7% On Friday

    Small cap National Health Partners is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." On Friday, National Health Partners surged 816.7% to $0.044 for a market cap of $107,933 plus NHPR is down 78% over the past year and up 923.3% since June 2012 according to Google Finance.

Friday, November 21, 2014

Top 10 Promising Stocks To Own For 2014

Back in the golden age of big American concept cars, wonder machines that spoke to an era of almost unlimited dreams and prosperity, came one especially beautiful Lincoln.

The 1955 Indianapolis Exclusive Study showed what can happen when one of the better Italian design houses is set loose on one of the outlandishly huge chassis of the era. The result is a big car that combined American swagger with continental flair.

In this case, the body comes from Gian Carlo Boano, a promising young designer of the era, and the car itself is going on the block Thursday at the Art of the Automobile Event being held jointly by RM Auctions and Sotheby's in New York. The one-off Lincoln is valued at $2 million to $2.5 million.

The car made its big debut at the 37th Salone dell'Automobile in Turin in 1955. At the time, Lincoln, Ford's premium division, couldn't have been hotter, as the hit song Hot Rod Lincoln would later attest.

Hot Gold Stocks To Own For 2015: GT Advanced Technologies Inc (GTAT)

GT Advanced Technologies Inc., incorporated on September 27, 2006, is diversified technology company with crystal growth equipment and solutions for the global solar, light emitting diode (LED) and electronics industries. The Company operates in three segments: its polysilicon business, its photovoltaic (PV), business and its sapphire business. The Company's principal products are Silicon Deposition Reactors (SDR) and related equipment used to produce polysilicon, the key raw material used in silicon-based solar wafers and cells; Advanced sapphire crystallization furnaces (ASF) which are used to crystallize sapphire boules, and Directional solidification (DSS) furnaces and related equipment used to cast multicrystalline and MonoCast crystalline silicon ingots. On January 7, 2013, the Company announced the idling of its HiCz pilot manufacturing facility in Hazelwood, Missouri. On November 8, 2012, the Company acquired certain assets of Twin Creeks Technologies, Inc. (Twin Creeks). In May 2013, the Company acquired the business of Thermal Technology LLC.

PV Business

The focus of the Company's PV business is the development, manufacture and sales of crystallization growth furnaces to produce silicon ingots used in the production of solar wafers. The Company's principal product line has been the DSS family of casting furnaces that are used to produce multicrystalline ingots and MonoCast ingots. As of December 31, 2012, the Company shipped approximately 3,300 DSS crystallization furnaces. The ingots are used to make photovoltaic (PV) solar wafers and cells. HiCz, or continuous Czochralski (Cz) growth process, produces monocrystalline ingots that are designed to produce more efficient wafers. The Company�� DSS furnace is a specialized furnace used to melt polysilicon and cast multicrystalline ingots. Multicrystalline ingots are used to produce solar wafers, which ultimately become solar cells. The Company markets its DSS crystallization furnaces under the names DSS450HP and DSS6! 50. The Company's largest capacity DSS furnace, the DSS650, is capable of producing ingots that weigh up to 650 kilograms using standard silicon feedstock. In January 2012, the Company introduced its MonoCast silicon casting technology that uses the DSS furnace architecture to produce ingots comprised of a high percentage of monocrystalline material. The Company is markets MonoCast technology under the name DSS450 MonoCast.

The Company�� ancillary equipment provides operators with material handling assistance during the preparation of the crucible before it is loaded with silicon and during the loading and unloading of the crucible into the DSS furnace chamber at the start of the growth process and out of the DSS furnace chamber at the conclusion of the ingot growth process. The Company's ancillary equipment includes crucible coating stations, crucible manipulators, loaders/unloaders, extraction tools and other material handling systems required to safely transport material during the ingot growth process. The Company sells replacement parts and consumables used in its DSS furnaces and other PV equipment.

Polysilicon Business

The Company's polysilicon business offers Silicon Deposition Reactors, which utilize the chemical vapor deposition process, and related trichlorosilane (TCS) technology and equipment along with engineering services to existing polysilicon producers and new market entrants. The Company's polysilicon business focuses on product design, quality control, engineering services, project management and process development related to the production of polysilicon. It markets its SDR reactors under the names SDR300, SDR400, SDR 500 and SDR 600. The Company provides equipment, technology and engineering services for the production and purification of TCSand silane. This hydrochlorination technology eliminates the need for silicon tetrachloride converters which are required when using certain other polysilicon production technology. The Company also pr! ovides an! cillary equipment and technologies for producing seed rods used in its SDR reactors and for handling and processing the polysilicon rods into a finished product.

Sapphire Business

The Company's sapphire business markets and sells of the Company's ASF systems to customers to enable them to produce sapphire material. The Company also produces sapphire material, on a limited basis, for the LED and other specialty markets at its sapphire pilot production facility in Massachusetts. Its ASF systems produce monocrystalline sapphire material, referred to as sapphire boules. The sapphire boules are used to make sapphire wafers, a substrate for manufacturing LEDs, as well as sapphire blanks and windows for such applications as medical devices and watch crystals. The Company's ASF technology is based on the heat exchanger method (HEM), which is a directional solidification technique, which crystallizes the sapphire meltstock material during the growth process. The Company also uses the facility as a research and development (R&D) center to test new technology developments prior to commercial release. The Company markets and sells its ASF systems under the name ASF100. The Company also provides engineering and product design, quality control, process engineering, engineering services and field services related to the operation of its ASF furnaces. The Company produces sapphire material on a limited basis at its pilot production facility in Massachusetts. The Company sells this material to customers in the LED and other markets, such as the aerospace, defenses and medical device.

The Company manufactures and sells two principal types of sapphire materials: hems Sapphire Material and Titanium-doped Sapphire (Ti:Sapphire) Material. Using the material derives from the sapphire boule generated with its ASF furnaces, the Company cut the sapphire material in a number of different dimensions and crystal orientations, in form factors such as cores, rods, blanks, windows and tubes. The! Company ! generates sapphire boules that are doped with titanium. The Company provides certain finishing and polishing for its Ti:Sapphire material.

The Company competes with ALD Vacuum Technologies AG, JYT Corporation, Ferrotec Corporation, PVA TePla AG, Centrotherm Elektrische Anlagen GmbH & Co., Jing Gong Technology, Zhejiang Jingsheng Mechanical & Electrical Co., Ltd, MSA Apparatus Construction for Chemical Equipment Ltd, Centrotherm Elektrische Anlagen GmbH & Co., Morimatsu Industry Co. Ltd., Poly Plant Project, Inc., Hemlock Semiconductor Corporation, Wacker Chemie AG, MEMC Electronic Materials, Inc., Renewable Energy Corporation ASA, Thermal Technology LLC, Advanced Renewable Energy Company, LLC, Rubicon Technology, Inc., Sapphire Technology Co. Ltd. (Korea), Kyocera International Inc., Saint-Gobain, Gavish Inc., and Monocrystal.

Advisors' Opinion:
  • [By Peter Graham]

    The Q1 2014 earnings report for advanced materials stock GT Advanced Technologies Inc (NASDAQ: GTAT), a potential peer of stocks like Corning Incorporated (NYSE: GLW), UniPixel Inc (NASDAQ: UNXL) and Universal Display Corporation (NASDAQ: OLED), is due out after the market closes later today. Aside from the GT Advanced Technologies earnings report, it should be said that Corning Incorporated already�reported earnings on Monday, April 28 while UniPixel Inc� and Universal Display Corporation are both�scheduled to release earnings after the market closes on Thursday. All of these stocks are interesting because all supply advanced materials to consumer electronics, mobile device, solar and organic light emitting diode (OLED) or light emitting diode (LED) makers.

  • [By Rustic Nomad]

    The polysilicon market environment has also continued to improve, with supply tightening up considerably and prices rising. This has opened up solid opportunities for a company like GT Advanced Technologies (GTAT), which seems set to improve at a great pace. Let's take a look at GT's prospects and see how it might do in the long run.

  • [By Grace L. Williams]

    Up next is GT Advanced Technologies (GTAT), a manufacturer and marketer of materials for optical, laser and solar applications. Highlights for the quarter here include CEO Thomas Gutierrez, who sold and exercised-and-sold 461,300 shares for $8 million, and General Counsel Hoil Kim, who exercised-and-sold 222,800 shares for $3.3 million through 10b5-1 planned sales and regular sales. InsiderScore comments:

Top 10 Promising Stocks To Own For 2014: NxStage Medical Inc.(NXTM)

NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product, the NxStage System One, is a portable hemodialysis system used for home hemodialysis and a range of dialysis therapies for chronic home hemodialysis treatment, and the treatment of acute kidney failure and fluid overload. The NxStage System One comprises components, such as The NxStage Cycler, a compact portable electromechanical device; The NxStage Cartridge, a single-use integrated treatment cartridge; and premixed dialysate for hemodialysis applications. The company also sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD); and needles and blood tubing sets primarily to dialysis clinics for the treatment of ESRD. NxStage Medical, Inc. markets its products primaril y to dialysis clinics, nephrologists, and hospitals through distributors and sales representatives in the United States, Mexico, and Europe. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. founded in 1998 and is headquartered in Lawrence, Massachusetts.

Advisors' Opinion:
  • [By John Udovich]

    Small cap dialysis stock Rockwell Medical Inc (NASDAQ: RMTI) looks set to decline when the market opens after Brean Capital initiated coverage with a sell rating and a price target of $4.00, meaning it might be time to take a closer look at what is going on with the stock along with�the performance of large cap dialysis stocks DaVita Healthcare Partners (NYSE: DVA)�and Fresenius Medical Care (NYSE: FMS) along with small cap dialysis stocks NxStage Medical, Inc (NASDAQ: NXTM).�

Top 10 Promising Stocks To Own For 2014: BV Financial Inc (BVFL)

BV Financial, Inc. (BV Financial), is a federally-chartered savings and loan holding company and the holding company for Bay-Vanguard Federal, a federally-chartered savings bank. BV Financial�� business activity is the ownership of the Bay-Vanguard Federal. The Company operates as a community-oriented financial institution offering traditional financial services to consumers and businesses in its market area. It attracts deposits from the general public and uses those funds to originate one- to four-family real estate, mobile home, construction, multi-family, commercial real estate, and consumer loans, which it hold for investment. The Company operates two branch offices in Baltimore City and two branch offices in Anne Arundel County. In June 2013, BV Financial Inc's Bay-Vanguard Federal Savings Bank acquired Vigilant Federal Savings Bank.

Lending Activities

The Company�� loan portfolio consists primarily of one- to four-family residential real estate loans. Its loan portfolio includes mobile home loans, construction loans, multi-family, commercial real estate loans, and consumer loans. As of June 30, 2009, Bay-Vanguard Federal had no loans that were held for sale. Its primary lending activity is the origination of mortgage loans to enable borrowers to purchase or refinance existing homes in its market area. It only offer fixed and adjustable rate mortgage loans and primarily with terms of 15, 20 or 30 years. The Company also offers adjustable-rate mortgage loans with interest rates and payments that adjust annually or every three years.

The Company originates mobile home loans directly and purchase mobile home loans from Forward National and Mainland Financial, which specialize in mobile home lending. As of June 30, 2009, 13.6% of its mobile home portfolio was originated by directly and 70.4% and 16% was purchased from Forward National and Mainland Financial, respectively. As of June 30, 2009, it had 340 mobile home loans, the average size of which was appr! oximately $34,000. Its mobile home loans, which are made primarily to borrowers in Maryland and Pennsylvania, have terms of up to 25 years and fixed interest rates. It originates loans to individuals and, to a lesser extent, builders to finance the construction of residential dwellings. It also make construction loans for commercial development projects, including condominiums, apartment buildings, mixed-use properties with residential units, as well as retail space and owner-occupied properties used for business.

The Company offers fixed-rate and adjustable-rate mortgage loans secured by multi-family and commercial real estate. Its multi-family and commercial real estate loans are secured by condominiums, apartment buildings and mixed-use properties with residential units, as well as retail space. It originates multi-family and commercial real estate loans for terms up to 25 years. The Company�� other consumer loans are primarily loans secured by passbook or certificate accounts, automobile and boat loans and secured personal loans.

Investment Activities

The Company has legal authority to invest in various types of liquid assets, including the United States Treasury obligations, securities of various federal agencies and municipal governments, deposits at the Federal Home Loan Bank of Atlanta and certificates of deposit of federally insured institutions. As of June 30, 2009, its investment portfolio totaled $13.8 million and consisted primarily of the United States Treasury obligations and federal agency securities, mortgage-backed securities issued primarily by Fannie Mae, Freddie Mac and Ginnie Mae, and a mutual fund that invests in adjustable-rate mortgages.

Deposit Activities and Other Sources of Funds

Deposits and loan repayments are the major sources of its funds for lending and other investment purposes. The Company�� deposits are attracted from within its market area through the offering of selection of deposit instruments,! includin! g checking accounts, negotiable order of withdrawal (NOW) and money market accounts, passbook and savings accounts, and certificates of deposit. As of June 30, 2009, its core deposits, which consist of savings, NOW and money market accounts, consists 49% of its deposits.

Advisors' Opinion:
  • [By CRWE]

    Today, BVFL remains (0.00%) +0.000 at $6.52 thus far (ref. google finance Delayed: 3:05PM EDT September 4, 2013).

    BV Financial, Inc. previously reported net income of $488,000, or $0.20 per diluted share, for the year ended June 30, 2013 compared to $1,073,000, or $0.46 per diluted share, for the year ended June 30, 2012. Results for 2013 were impacted by the acquisition of Vigilant Federal Savings Bank on May 31, 2013. As a result of the acquisition, BV Financial acquired $47.5 million in assets, $44.4 million in liabilities and created $119,000 in goodwill.

Top 10 Promising Stocks To Own For 2014: First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN)

First Trust NASDAQ Clean Edge US (ETF) seeks investment results that correspond to the price and yield of an equity index of the NASDAQ Clean Edge U.S. Liquid Series Index. It is a market capitalization weighted index designed to track the performance of clean energy companies that are publicly traded in the United States and includes companies engaged in manufacturing, development, distribution and installation of emerging clean-energy technologies, including solar photovoltaics, biofuels and advanced batteries.

The NASDAQ Clean Edge U.S. Liquid Series Index is a modified market cap weighted index in which larger companies receive a larger index weighting. First Trust Advisors L.P. is the adviser of the fund.

Advisors' Opinion:
  • [By Todd Shriber, ETF Professor]

    The news was predictably good for a pair of ETFs that should be known as "Tesla ETFs." The Market Vectors Global Alternatve Energy ETF (NYSE: GEX) and the First Trust NASDAQ Clean Edge Green Energy Index Fund (NASDAQ: QCLN) both traded higher on a down day for U.S. stocks, rising to within pennies of their previous 52-week highs.

Top 10 Promising Stocks To Own For 2014: BBVA Banco Frances S.A. (BFR)

BBVA Banco Franc茅s S.A., together with its subsidiaries, provides various financial services to corporations, medium and small companies, and individual customers in the Republic of Argentina. The company offers checking and savings accounts, time deposits, and investment accounts. It also provides short and long-term loans to companies, overdraft lines of credit, discounted instruments, loans to financial institutions and the governmental sector, collateral loans, and real estate mortgage, as well as consumer loans comprising credit card loans and other consumer loans. In addition, the company offers home and personal accident insurance; payroll services; asset management services; and insurance advisory services to customers in the areas of coverage of risks related to life, personal accidents and home insurance, and automated teller machine (ATM) robbery insurance. Further, it provides foreign trade services, including letters of credit, collections, bank drafts, fund transfers, and foreign currency transactions; and electronic banking, ATM, self-service terminals, Internet and mobile banking, call center, and trust services. Additionally, the company engages in capital market and securities activities, principally underwriting and placement of corporate bonds, commercial paper, and equity securities; corporate advisory; and securities brokerage. As of December 31, 2011, it operated 268 branches comprising 240 retail branches, 28 branches specialized in small and medium enterprises segment, 13 in-company branches, 7 corporate banking units, and 3 points of sale, as well as 654 ATM�s and 695 quick deposit boxes. The company was formerly known as Banco Frances del Rio de la Plata S.A. and changed its name to BBVA Banco Franc茅s S.A. in October 2000. The company was founded in 1886 and is based in Buenos Aires, the Republic of Argentina. BBVA Banco Franc茅s SA operates as a subsidiary of Banco Bilbao Vizcaya Argentaria, S.A.

Advisors' Opinion:
  • [By Federico Zaldua]

    Banco Frances (BFR), 75% controlled by Banco Bilbao Viscaya Argentaria, is among the biggest banks in Argentina. The bank has the smallest exposure to Argentina's public debt out of the three banks analyzed in the article and presents the lowest pace of growth. That said, its one of the healthiest banks in the country given that it has the lowest NPL ratio and the highest reserve ratio to absorb potential losses. The bank also trades cheaply at 3.5 times P/E and 85% its book value. Being more expensive (although still very cheap relative to the sector's average) and with the lowest liquidity among this group of three, I would exclude Banco Frances from my Argentinean bank portfolio.

Top 10 Promising Stocks To Own For 2014: Coffee Holding Co. Inc.(JVA)

Coffee Holding Co., Inc. engages in manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees in the United States and Canada. The company offers three categories of products: wholesale green coffee, private label coffee, and branded coffee. The wholesale green coffee product category consists of unroasted raw beans imported from worldwide that are sold to roasters and coffee shop operators in approximately 90 varieties. The private label coffee product category includes coffee roasted, blended, packaged, and sold under the specifications and names of others. As of October 31, 2010, the company supplied private label coffee under approximately 34 different labels to wholesalers and retailers in cans, brick packages, and instants in various sizes. The branded coffee product category comprises coffee roasted and blended to the company's own specifications and offered under its seven brand names in various segments of the market. The company also offers other products, including trial-sized mini-brick coffee packages; specialty instant coffees; instant cappuccinos and hot chocolates; and tea line products. Its coffee brands include Cafe Caribe, S&W, Cafe Supremo, Don Manuel, Fifth Avenue, Via Roma, IL CLASSICO, and Entenmann. Coffee Holding Co., Inc. markets its private label and wholesale coffee through trade shows, industry publications, face-to-face contacts, internal sales force, and non-exclusive independent food and beverage sales brokers, as well as through its Web site, coffeeholding.com. The company was founded in 1971 and is headquartered in Staten Island, New York.

Advisors' Opinion:
  • [By James E. Brumley]

    What do you get when you cross a Coffee Holding Co., Inc. (NASDAQ:JVA) with a Medical Marijuana Inc. (OTCMKTS:MJNA) and a Kraft Foods Group Inc. (NASDAQ:KRFT)? No, it's not a setup for a punch line - there's a legitimate answer. And that answer is, Latteno Food Corp. (OTCMKTS:LATF).

Top 10 Promising Stocks To Own For 2014: Amicus Therapeutics Inc.(FOLD)

Amicus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, enhance the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its products under development include Amigal, which is in phase III for the treatment of Fabry disease; AT2220, which completed phase I study for the treatment of Pompe disease; and Plicera, that has completed phase I study for the treatment of Gaucher disease. The company has license and collaboration agreement with Glaxo Group Limited to develop and commerc ialize Amigal. The company was founded in 2002 and is based in Cranbury, New Jersey.

Advisors' Opinion:
  • [By Rick Munarriz]

    5. You've got to know when to FOLD 'em
    Investing in biotech upstarts can be pretty risky, and Amicus Therapeutics (NASDAQ: FOLD  ) investors learned that the hard way this week.

Monday, November 17, 2014

Top Gold Stocks To Watch Right Now

Gold and copper miner Freeport-McMoRan (NYSE: FCX  ) will pay its shareholders a supplemental dividend of $1.00 per share upon the completion of its acquisition of Plains Exploration & Production (NYSE: PXP  ) , the company announced today. The supplemental payout will be in addition to the miner's regular quarterly dividend of $0.3125 per share.

Plains Exploration shareholders are set to vote on the $6.9 billion cash and stock deal today.

Additionally, Freeport's board of directors said they would pay to shareholders of Plains Exploration�a $3.00-per-share cash dividend upon completion of the transaction.

Freeport Chairman James R. Moffett and President and CEO Richard C. Adkerson said in a joint statement: �"This dividend in no way changes our commitment to reduce debt on completion of the pending acquisitions.�The planned asset sales, combined with our significant cash flows and disciplined approach to investing in capital projects, will enable us to meet our target of reducing debt to $12 billion over a three year period."

Hot Consumer Service Stocks To Invest In Right Now: NEW GOLD INC.(NGD)

New Gold Inc. engages in the acquisition, exploration, extraction, processing, and reclamation of mineral properties. The company primarily explore for gold, silver, and copper deposits. Its operating properties include the Mesquite gold mine in the United States; the Cerro San Pedro gold-silver mine in Mexico; and the Peak gold-copper mine in Australia. The company also has development projects, including the New Afton gold, silver, and copper project in Canada; and a 30% interest in the El Morro copper-gold project in Chile. The company was formerly known as DRC Resources Corporation and changed its name to New Gold Inc. in June 2005. New Gold Inc. was founded in 1980 and is headquartered in Vancouver, Canada.

Advisors' Opinion:
  • [By Ben Levisohn]

    January is nearing an end, and that means one thing: Gold miners will start announcing earnings. New Gold (NGD) will get things started on Feb 6, followed by Kinross Gold (KGC) on Feb. 12 and Goldcorp (GG) and Barrick Gold (ABX) on Feb. 13.

  • [By Ben Levisohn]

    Bridges favorite stocks include Goldcorp, Newmont, Eldorado Gold (EGO) and New Gold (NGD).

    Note, however, that these recommendations are all qualified in one way or another. Investors should keep that in mind before going all in on the gold miners.

  • [By Ben Levisohn]

    Even bad news has failed to dent the rise in gold stocks today. NewGold (NGD), for instance, has gained 1.8% to $7.49 despite the fact that the wall of one of its mines collapsed. The Wall Street Journal has the details:

Top Gold Stocks To Watch Right Now: Goldcorp Incorporated(GG)

Goldcorp Inc. engages in the acquisition, exploration, development, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America. It produces and sells gold, silver, copper, lead, and zinc. The company was founded in 1954 and is headquartered in Vancouver, Canada.

Advisors' Opinion:
  • [By Doug Ehrman]

    Goldcorp (NYSE: GG  ) recently reported quarterly earnings per share of $0.31, falling well short of analysts' consensus estimates of $0.38 and the $0.50 EPS the company earned in same period a year ago. Despite the miss, President and CEO Chuck Jeannes confirmed the company's full-year guidance, focusing on positive results, favorable growth prospects, and controlled costs. Goldcorp has faced the same pressures that have plagued the two top gold producers, Barrick Gold (NYSE: ABX  ) and Newmont Mining (NYSE: NEM  ) ��weakening gold prices and escalating costs. Ultimately, Jeannes believes the 12-year bull market remains intact, which, if true, makes recent weakness in the stock a buying opportunity.�

Top Gold Stocks To Watch Right Now: Golden Star Resources Ltd(GSS)

Golden Star Resources Ltd., a gold mining and exploration company, through its subsidiaries, engages in the acquisition, exploration, development, and production of gold properties. It owns and operates the Bogoso/Prestea gold mining and processing operation that covers approximately 40 kilometers of strike along the southwest-trending Ashanti gold district in western Ghana; and the Wassa open-pit gold mine located to the east of Bogoso/Prestea in southwest Ghana. The company also has an 81% interest in the Prestea underground gold mine located in Ghana. In addition, it holds interests in various gold exploration projects in Ghana, Sierra Leone, Burkina Faso, Niger, and Cote d?Ivoire, as well as holds and manages exploration properties in Brazil in South America. The company was founded in 1984 and is based in Littleton, Colorado.

Advisors' Opinion:
  • [By Rich Duprey]

    Clash of the titans
    When bears are raging on the gold bullion market, it's not surprising to see gold stocks getting mauled as well. Golden Star Resources (NYSEMKT: GSS  ) was the biggest loser in the sector, losing a quarter of its market cap on no company-specific news, though a report last Friday indicated that a large number of hedge funds had recently dumped their positions in the mid-tier miner. Yet it wasn't all that much better among the majors, either, as Barrick Gold (NYSE: ABX  ) fell almost 13% and Kinross Gold (NYSE: KGC  ) was down 14%.

  • [By Patricio Kehoe] some future and gave several reasons for my bearish stance towards the stock. A small market, high geopolitical risk in some of the countries the firm operates, along with overexpansion in times of fluctuating gold prices gave tune to the massive shedding of shares by investment gurus. Five months have past since I last considered Golden Star�� potential, and everything indicates the situation has not changed.

    Guru Activity Shows a Clear Tendency

    Steven Cohen (Trades, Portfolio), Chuck Royce (Trades, Portfolio) and Arnold Schneider (Trades, Portfolio), had already sold their entire holdings in the company by October 2013, indicating they had little faith in the gold miner�� recovery. By the end of the year, Jim Simons' (Trades, Portfolio) Renaissance Technologies took a similar decision, reducing its stake in the firm by 32%. This tendency towards the sale of Golden Star stock was duly noted by investors and analysts alike, and concurs with the company�� poor performance.

    A Look at the Numbers

    In an industry plagued by fluctuating metal prices, operating with lofty margins can be quite helpful. Yet Golden Star cannot afford such luxuries. With an operating margin of 0.1% and a net margin of -56.8% the firm is in a tight spot, especially when compared to the industry average. Unlike its industry peers��median, which are of 2.26% and -0.09%, respectively, the Toronto-based gold miner is struggling to generate decent cash flow levels. Further metrics depict a even worse situation for shareholders: return on equity is currently at -370% and revenue growth is estimated to reach a poor 2.5%. Purchasing overpriced assets, relative to current gold prices, is surely one of the reasons for such grim figures, as financial losses have taken their toll on Golden Star.

    The announcement of its 2013 full year, and fourth quarter earnings only helped to add to shareholders��concerns. A 15% decline in revenue was expected by those

  • [By Sean Williams]

    Golden Star Resources (NYSEMKT: GSS  )
    It's simple physics: The bigger they are, the harder they fall. When gold prices nosedived earlier this week, gold miners with historically higher operating costs took the brunt of the hit. For the most part, that meant that development-stage miners, and those operating in Africa, where labor and political costs make cost-effective mining a challenge, took it on the chin. Possibly no stock was hammered more than Golden Star Resources, a gold miner in Ghana, which lost about one-quarter of its value on Monday alone.

  • [By Patricio Kehoe] ating price of the commodity, along with the geopolitical risks involved in mining in African nations such as Ghana, are just two of the obstacles the firm is facing. In addition, as one of the smallest gold mining firms in the industry, with a market cap of just $122 million, Golden Star has had a very difficult time financing its latest expansion projects. With share prices tumbling towards all-time lows, gurus such as Steven Cohen, Chuck Royce and Arnold Schneider have already sold out their positions in the troubled firm.

    Why Have Gurus Lost Faith in Golden Star?

    Despite aggressive expansion over the past decade, the Toronto-based gold mining firm has not been able to take advantage of its increased production output. Gold prices might have exploded over a ten-year period, yet the recent six-month decline has put a huge strain on Golden Star. The expedited maturation of its mines is particularly troubling, since the accelerated extraction rates, which allowed for short-term profits, are now falling considerably. The impact of the company�� excessive overproduction on profits and growth is clear: decreasing gold reserves mean less production, and thus reduced revenue for the gold miner. When the decline in metal prices are taken into account, the outlook is even more grim.

    In addition to overexpansion at the wrong time, Golden Star�� position has weakened due to its comparably less efficient operations. Unlike industry peers, such as IamGold Corp. (IAG) or Gold Fields Ltd. (GFI), the majority of the Toronto-based miner�� assets contain refractory ore, which is far more expensive to extract than non refractory ore. And, in an attempt to switch production to the lower cost gold ore, and thus increase margins, Golden Star has depleted its mines��non refractory ore. With low reserves and mounting cash costs, the firm inevitably turned to new acquisitions.

    Overpriced Acquisitions and Geopolitical Risk

    The purchase

Top Gold Stocks To Watch Right Now: Thompson Creek Metals Company Inc.(TC)

Thompson Creek Metals Company Inc., through its subsidiaries, engages in mining, milling, processing, and marketing molybdenum products in the United States and Canada. The company?s principal properties include the Thompson Creek Mine and mill in Idaho; a metallurgical roasting facility in Langeloth, Pennsylvania; and a joint venture interest in the Endako Mine, mill, and roasting facility in British Columbia. It also holds interests in development projects comprising the Davidson molybdenum property and the Berg copper-molybdenum-silver property located in northern British Columbia; the Howard?s Pass property, a lead and zinc project situated in the Yukon territory-northwest territories border; and the Maze Lake property, a gold project located in the Kivalliq district of Nunavut. The company produces molybdenum products, primarily molybdic oxide and ferromolybdenum, as well as soluble technical oxide, pure molybdenum tri-oxide, and high purity molybdenum disulfide. As o f December 31, 2010, its consolidated recoverable proven and probable ore reserves totaled 462.2 million pounds of contained molybdenum in the Thompson Creek Mine and the Endako Mine. The company was formerly known as Blue Pearl Mining Ltd. and changed its name to Thompson Creek Metals Company Inc. in May 2007. Thompson Creek Metals Company Inc. is based in Denver, Colorado.

Advisors' Opinion:
  • [By Garrett Cook]

    Monday morning, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from AK Steel Holding (NYSE: AKS) and Thompson Creek Metals Company (NYSE: TC).

  • [By Jon C. Ogg]

    Thompson Creek Metals Co. Inc. (NYSE: TC) was at 54% discount to its book value of $8.30 per share at the time, and the stock price of $3.90 is up from $3.03 Deutsche Bank’s team nailed upside of more than 28% here. Its price target was $4 at the time versus a consensus target of $4.50 at the time. The 52-week range here is $2.42 to $4.55, but we would point out that the consensus price target is $3.93.

  • [By Selena Maranjian]

    The biggest new holdings are Chesapeake Energy�puts, and shares of Discovery Communications. Other new holdings of interest include Halcon Resources (NYSE: HK  ) , and Thompson Creek Metals (NYSE: TC  ) . Oil and gas company Halcon, operating in the promising Bakken region, as well as Texas's productive Eagle Ford shale region, among others, is expected to grow by 30% annually over the coming years. It recently reported 2012 net daily production 128% higher than year-ago levels, and proven reserves up 417%. Halcon was recently one of my colleague Joel South's top two energy holdings, and analysts at Stifel recently upped its rating�from Hold to Buy.

  • [By Garrett Cook]

    Basic materials shares fell 1.04 percent on Friday. Top losers in the sector included Cliffs Natural Resources (NYSE: CLF), down 5.5 percent, and Thompson Creek Metals Company (NYSE: TC), off 5.4 percent.

Top Gold Stocks To Watch Right Now: Sibanye Gold Ltd (SBGL)

Sibanye Gold Limited (Sibanye Gold), formerly GFI Mining South Africa (Pty) Limited, incorporated on December 12, 2002, is a producer of gold in South Africa. Sibanye Gold is primarily engaged in underground and surface gold mining and related activities, including extraction, and processing. Sibanye Gold�� operations are located in South Africa. Its principal mining operations include Kloof-Driefontein Complex (KDC) and Beatrix. Exploration activities are focused on the extension of existing ore bodies and identification of new ore bodies at existing sites. As of January 10, 2013, Sibanye Gold mined only gold, with silver as a by-product.

KDC Operation

The KDC mine is located in the Gauteng Province of South Africa in the Far West Rand mining district, some 60 kilometers southwest of Johannesburg. KDC consists of the Driefontein and Kloof mines. As of January 10, 2013, KDC is consisted of 13 producing shaft systems that mine different contributions from pillars and open ground and five gold plants of which two process mainly underground ore and three process mainly surface material. Driefontein is situated some 70 kilometers west of Johannesburg. Kloof is situated in the Magisterial District of Westonaria, some 60 kilometers west of Johannesburg.

Beatrix Operation

The Beatrix operation is located in the Free State Province of South Africa, some 240 kilometers southwest of Johannesburg, near Welkom and Virginia, and consists of the Beatrix mine. Beatrix operates under mining rights covering a total area of approximately 16 800 hectares. As of January 10, 2013, Beatrix had four shaft systems, with five ventilation shafts to provide additional up-cast and down-cast ventilation capacity and is serviced by two metallurgical plants. It is a shallow to intermediate-depth mining operation, at depths between 700 meters and 2 200 meters below surface. The mine has a refrigeration and cooling infrastructure in both its North and West Sections. Beatrix is man! aged as three operational sections: the North Section (consists of Shaft No. 3), the South Section (consists of Shaft No. 2 and Shaft No. 1) and the West Section (consists of Shaft No. 4).

Advisors' Opinion:
  • [By Lisa Levin]

    Gold: This industry jumped 1.20% by 11:40 am. The top performer in this industry was Sibanye Gold (NYSE: SBGL), which rose 3.2%. Gold futures gained 0.44% to trade at $1,281.00 an ounce.

Top Gold Stocks To Watch Right Now: Renaissance Oil Corp (ROE)

Renaissance Oil Corp, formerly San Antonio Ventures Inc., is developing a diversified shale and mature fields portfolio for development in Mexico and Spain. The Company is partnered with Grupo SAMCA, a diverse industrial with operations in energy, mining, industrial minerals, agriculture, environmental and various other business lines in Spain. Advisors' Opinion:
  • [By Holly LaFon]

    During the year, we exited more holdings than we added, making the portfolio more concentrated. The exits were driven by the inability of newer positions to meet our milestones. The business environment in many parts of Asia has been difficult for the past few years, reflective of tougher lending conditions, and a moderation in growth. All this has translated into lower returns on equity (ROE) for many companies, and is one of the key reasons behind Asia�� underperformance relative to many other parts of the world. Some of the decline in ROE is likely structural, as may be the case for the industrial sector in China. However, we also believe that with stabilizing sales growth and lower inputs costs, there is a possibility that margins may stabilize and start to recover over the next few years.

Sunday, November 16, 2014

Top 5 Medical Companies To Buy For 2014


Source: Adrian Clark, Flickr

Think of medical care as a supply chain that flows from a starting point of insurers and information technology companies behind the scenes to the point-of-service provider, your physician. In between, there are a number of important facilitators, one of which is the healthcare equipment and supplies industry.

Given the fact that healthcare is among the fastest growing industries, the vital role healthcare equipment and supply companies could play in the coming years might make them attractive investment opportunities.

But this only holds true if you understand the basics of the sector with regard to how it works, its history and evolution, and what advantages and headwinds you might face as an investor. Let's have a closer look.

What are healthcare equipment and supplies?

Healthcare equipment and supplies are used by physicians and other medical personnel to help aid in patient diagnosis, monitoring, and treatment.

10 Best Up And Coming Stocks To Own For 2015: Biodel Inc (BIOD)

Biodel Inc. (Biodel), incorporated on December 3, 2003, is a development-stage speciality biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its formulation technologies to existing drugs. Its advanced program involves developing formulations of injectable recombinant human insulin (RHI). In addition to its ultra-rapid-acting insulin formulations, the Company has developed prototype formulations of a liquid glucagon, a basal insulin and a glucose responsive insulin, in each case for use by patients with diabetes. RHI-based formulation known as Linjeta was the subject of a New Drug Application (NDA).

The Company has two pivotal Phase III clinical trials with its preferred commercial formulation of Linjeta prior to re-submitting the NDA. In August 2011, it completed patient visits and analyzed top-line data from the first Phase 1 clinical trial of two RHI-based formulations. The trial was a single-center, randomized, double-blind, three-period crossover trial in 18 subjects with Type 1 diabetes. The purpose of the trial was to evaluate the pharmacokinetic and pharmacodynamic characteristics and injection site toleration of BIOD-105 and BIOD-107, as compared to the insulin analog marketed as Humalog. The Company conducted Phase I, Phase II and Phase III clinical trials comparing the performance of its Linjeta formulation of RHI to either Humulin, which is a branded formulation of RHI or Humalog. Its pivotal Phase III clinical trials were open-label, parallel group, randomized trials conducted at centers in the United States, Germany and India.

The Company competes with Eli Lilly, Novo Nordisk, Sanofi-Aventis, Halozyme Therapeutics, Inc. and MannKind Corporation.

Advisors' Opinion:
  • [By Roberto Pedone]

    One under-$10 specialty biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Biodel (BIOD), which is focused on the development and commercialization of innovative treatments for diabetes. This stock has been hit hard by the bears over the last three months, with shares down by 24%.

    If you take a look at the chart for Biodel, you'll notice that this stock is ripping higher here right off its 50-day moving average of $2.32 a share with strong upside volume. Volume on Thursday has so far registered over 750,000 shares, which is well above its three-month average action of 445,084 shares. This move is quickly pushing shares of BIOD within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in BIOD if it manages to break out above some near-term overhead resistance levels at $2.52 to $2.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 445,084 shares. If that breakout triggers soon, then BIOD will set up to re-test or possibly take out its next major overhead resistance levels $3 to its 200-day moving average of $3.39 a share. Any high-volume move above $3.39 will then give BIOD a chance to tag $4 a share.

    Traders can look to buy BIOD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $2.10 a share. One can also buy BIOD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Monica Gerson]

    Biodel (NASDAQ: BIOD) is expected to post a Q1 loss at $0.24 per share.

    First Majestic Silver (NYSE: AG) is estimated to post its Q1 earnings at $0.10 per share on revenue of $63.35 million.

Top 5 Medical Companies To Buy For 2014: Insys Therapeutics Inc (INSY)

Insys Therapeutics, Inc., incorporated on June 15, 1990, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company�� pharmaceuticals portfolio consists of one approved product and a number of product candidates targeting cancer-supportive care and cancer therapy. The Company�� product candidate includes Subsys, Dronabinol SG Capsule, Dronabinol RT Capsule, Dronabinol Oral Solution, Dronabinol Inhalation Device, and Dronabinol IV Solution. The Company is also developing cancer therapeutics, which is LEP-ETU, a formulation of paclitaxel, the active ingredient in the cancer drugs Taxol and Abraxane. On August 19, 2011, the Food & Drug Administration (FDA) approved its Dronabinol SG Capsule product, a generic equivalent to Marinol, for the treatment of chemotherapy induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS).

Subsys

The Company's Subsys is a single-use product that delivers fentanyl, an opioid analgesic, in seconds for transmucosal absorption underneath the tongue. Subsys is a transmucosal product to show pain relief when measuring the sum of pain intensity difference at five minutes in a Phase 3 breakthrough cancer pain (BTCP) clinical trial using fentanyl.

Dronabinol Product Family

The Company has an approved dronabinol product and is developing several dronabinol product candidates for the treatment of CINV and appetite stimulation in patients with AIDS, as well as other indications where dronabinol could have potential therapeutic benefits. Dronabinol, the active ingredient in Marinol, is a synthetic cannabinoid whose chemical name is delta-9-tetrahydrocannabinol (THC). Its portfolio consists of its Dronabinol SG Capsule product and Dronabinol RT Capsule product candidate, which are intended to be generic equi! valents to Marinol, in addition to three formulations, including Dronabinol Oral Solution. Dronabinol SG Capsule is a dronabinol soft gelatin capsule intended to be a generic equivalent to Marinol. Dronabinol RT Capsule is a dronabinol soft gel capsule that is stable at room temperature. Dronabinol Oral Solution is a ynthetic THC in an oral liquid formulation.

Cancer Therapeutics

In addition to its cancer-supportive care products, the Company intends to develop cancer therapeutics targeting limitations of existing commercial products. LEP-ETU, it advanced cancer therapeutic, is a NeoLipid liposomal, or microscopic membrane-like structure created from lipids, formulation that incorporates paclitaxel. LEP-ETU completed a Phase 2 clinical trial of 70 patients with metastatic breast cancer.

The Company competes with Cephalon, Inc., BioDelivery Sciences International, Inc., ProStrakan Group plc, Nycomed International Management GmbH, Archimedes Pharma Ltd., TEVA Pharmaceuticals USA, Watson Pharmaceuticals, Inc., AcelRx Pharmaceuticals, Inc., Akela Pharma Inc., Abbott Laboratories, Pharmaceutical International, Inc., Par Pharmaceutical Companies Inc., sanofi-aventis, Eisai Inc., Helsinn Group, Roche Holding AG, Par Pharmaceutical Companies Inc., GlaxoSmithKline plc, ProStrakan Group plc, Merck & Co, GW Pharmaceutical, A.P. Pharma, Inc., Aphios Corp., Roche Holding, Tesaro, Inc., Cornerstone Pharmaceutical, Inc., Bristol-Myers Squibb, Celgene Corporation, Laboratories, Amgen Inc., AstraZeneca PLC., Bayer AG, Biogen Idec Inc., Eisai Co., Ltd., F. Hoffmann- LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Onyx Pharmaceuticals Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.

Advisors' Opinion:
  • [By Roberto Pedone]

    One specialty pharmaceutical player that's quickly moving within range of triggering a big breakout trade is Insys Therapeutics (INSY), which develops and commercialize supportive care products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. This stock is off to a monster start in 2013, with shares up a whopping 434%.

    >>5 Stocks Insiders Love Right Now

    If you take a look at the chart for Insys Therapeutics, you'll notice that this stock has been uptrending strong for the last six months, with shares soaring higher from its low of $9.30 to its recent high of $53.64 a share. During that uptrend, shares of INSY have been making mostly higher lows and higher highs, which is bullish technical price action. Shares of INSY have recently pulled back to its 50-day moving average and the stock has now started to spike higher off that level. That spike is starting to push shares of INSY within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in INSY if it manages to break out above some near-term overhead resistance levels at $43.50 to $44.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 235,266 shares. If that breakout hits soon, then INSY will set up to re-test or possibly take out its next major overhead resistance levels at $47.25 to its all-time high at $53.64 a share.

    Traders can look to buy INSY off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $38.75 a share or near its 50-day at $36.73 a share. One can also buy INSY off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Matt Jarzemsky]

    Among companies that went public in the U.S. last year, FireEye has seen the second-biggest share rally since its IPO, trailing only pharmaceutical company Insys Therapeutics Inc.(INSY)

  • [By David Zeiler]

    2. Insys Therapeutics Inc. (Nasdaq: INSY): Insys is a biotech seeking to capitalize on the growing interest in medical marijuana by using a generic form of THC to create drugs to treat cancer pain. INSY had its IPO May 2 with an offer price of $8 a share. The stock rose 19.75% on its first day of trading. But investors really warmed up to Insys later; it currently trades at about $37.54, a 369.25% increase over the offer price.

Top 5 Medical Companies To Buy For 2014: Galena Biopharma Inc (GALE)

Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). On January 19, 2012, the Company initiated enrollment in its Phase 3 PRESENT clinical trial for NeuVax (E75 peptide plus GM-CSF) vaccine in low-to-intermediate HER2 1+ and 2+ breast cancer patients in the adjuvant setting to prevent recurrence (Clinicaltrials.gov identifier NCT01479244). The Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment study is a randomized, multicenter, multinational clinical trial that will enroll approximately 700 breast cancer patients. The Company�� Phase 2 trial of NeuVax achieved its primary endpoint of disease-free survival (DFS). On April 13, 2011, the Company completed its acquisition of Apthera, Inc.,(Apthera).

The Company focuses to start a Phase 2 trial comparing NeuVax in combination with trastuzumab (Herceptin) versus trastuzumab, alone, in a 300-patient, randomized study in the adjuvant breast cancer setting. The Company's second product candidate, Folate Binding Protein-E39 (FBP), is a vaccine, consisting of the peptides E39 and J65, aimed at preventing the recurrence of ovarian, endometrial, and breast cancers. On February 14, 2012, the Company announced the initiation of a Phase 1/2 clinical trial in two gynecological cancers: ovarian and endometrial adenocarcinomas. Folate binding protein has ! very limited tissue distribution and expression in non-malignant tissue and is over-expressed in more than 90% of ovarian and endometrial cancers, as well as in 20% to 50% of breast, lung, colorectal and renal cell carcinomas.

In April 2011, the Company acquired Apthera Inc and its NeuVax product candidate. The Company focuses on developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide, the advanced of which is NeuVax, which is targeted at preventing the recurrence of breast cancer. NeuVax has had positive Phase 1/2 clinical trial results for the prevention of breast cancer recurrence in patients who have had breast cancer and received the standard of care treatment (surgery, chemotherapy, radiotherapy and hormonal therapy as indicated). The Company had also initiated its Phase 3 PRESENT clinical trial of NeuVax for the prevention of breast cancer recurrence in early-stage low-to-intermediate HER2 breast cancer patients. NeuVax directs killer T-cells to target and destroy cancer cells that express HER2/neu, a protein associated with epithelial tumors in breast, ovarian, pancreatic, colon, bladder and prostate cancers. NeuVax is comprised of a HER2/neu-derived peptide called E75. E75 is a nine-amino acid sequence that is immunogenic (produces an immune response) and GM-CSF is a commercially available protein that acts to stimulate and activate components of the immune system such as macrophages and dendritic cells.

The Company also develops novel applications for NeuVax based on preclinical studies and phases 2 clinical trials which suggest that combining NeuVax and trastuzumab (Herceptin; Genentech/Roche) can increase antigen presentation by tumor cells by promoting receptor internalization and subsequent proteosomal degradation of the HER2 protein. The Company also is pursuing additional therapeutic indications for NeuVax that are in Phase 1/2 clinical trials. RXI-109, is a dermal anti-scarring therapy that targets! connecti! ve tissue growth factor (CTGF) and that may inhibit connective tissue formation in human fibrotic disease.

The Company competes with Roche Laboratories, Inc., Pfizer Inc., Bayer HealthCare AG, Sanofi-Aventis, US, LLC, Amgen, Inc., GlaxoSmithKline plc, Renovo Group plc, CoDa Therapeutics, Inc., Sirnaomics, Inc., FirstString Research, Inc., Merz Pharmaceuticals, LLC, Capstone Therapeutics, Halscion, Inc., Garnet Bio Therapeutics, Inc., AkPharma Inc., Promedior, Inc., Kissei Pharmaceutical Co., Ltd., Eyegene, Derma Sciences, Inc., Healthpoint Biotherapeutics, Pharmaxon, Excaliard Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Marina Biotech, Inc., Tacere Therapeutics, Inc., Benitec Limited, OPKO Health, Inc., Silence Therapeutics plc, Quark Pharmaceuticals, Inc., Rosetta Genomics Ltd., Lorus Therapeutics, Inc., Tekmira Pharmaceuticals Corporation, Arrowhead Research Corporation, Regulus Therapeutics Inc. and Santaris.

Advisors' Opinion:
  • [By James E. Brumley]

    It may look like little more than a choppy mess with just a quick glance at Galena Biopharma Inc. (NASDAQ:GALE). But, the more you study the chart - and the company - the more you realize there's enough long-term potential from the company's pipeline to keep spurring GALE in a generally-upward direction. In fact, the bulls look like they're on the verge of taking Galena Biopharma out of second gear and putting it into third. As such, it may not be a bad bet at this point.

  • [By Paul Ausick]

    Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analyst�� upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.

Top 5 Medical Companies To Buy For 2014: Johnson & Johnson(JNJ)

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune me diated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in Ne w Brunswick, New Jersey.

Advisors' Opinion:
  • [By Dan Caplinger]

    Johnson & Johnson (NYSE: JNJ  ) has posted gains of about 1.3% a day after the FDA gave its simeprevir hepatitis-C drug priority review status. The hep-C market has been a hotbed of activity lately, and the FDA move will help J&J to remain an important player in the niche and to potentially get a much faster approval process than would be available otherwise.